Edition:
United Kingdom

Galena Biopharma Inc (GALE.OQ)

GALE.OQ on NASDAQ Stock Exchange Capital Market

0.31USD
7:05pm GMT
Change (% chg)

$0.03 (+9.57%)
Prev Close
$0.28
Open
$0.28
Day's High
$0.32
Day's Low
$0.28
Volume
92,383
Avg. Vol
101,692
52-wk High
$3.60
52-wk Low
$0.26

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.158
Jun '17 0.00 -0.190
Mar '17 0.00 -0.086
FY 2016 Dec '16 0.00 -0.171
Sep '16 0.00 -0.415
Jun '16 0.00 0.893
Mar '16 0.00 -1.461
FY 2015 Dec '15 0.00 -1.334
Sep '15 0.00 -0.785
Jun '15 3.38 -1.941
Mar '15 0.00 -1.221
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 1 0.00 0.00 0.00 0.00
Quarter Ending Mar-18 1 0.00 0.00 0.00 0.00
Year Ending Dec-17 1 0.00 0.00 0.00 0.00
Year Ending Dec-18 1 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Dec-17 1 -0.15 -0.15 -0.15 -0.66
Quarter Ending Mar-18 1 -0.14 -0.14 -0.14 -0.61
Year Ending Dec-17 1 -0.59 -0.59 -0.59 -2.52
Year Ending Dec-18 1 -0.84 -0.84 -0.84 -1.93
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.14 32.93
P/E High - Last 5 Yrs. -- 40.91 45.62
P/E Low - Last 5 Yrs. -- 23.80 24.34
Beta 2.02 0.90 0.88
Price to Sales (TTM) -- 3.93 5.40
Price to Book (MRQ) 0.80 4.81 5.38
Price to Tangible Book (MRQ) -- 5.53 6.78
Price to Cash Flow (TTM) -- 23.04 23.45
% Owned Institutions 28.27 0.88 1.40

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.52
Dividend 5 Year Growth Rate -- 4.33 5.17
Payout Ratio(TTM) -- 45.73 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 3.57 9.00
Sales (TTM) vs TTM 1 Yr. Ago -- 4.66 5.38
Sales - 5 Yr. Growth Rate -- 10.11 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -121.26 16.54 19.67
EPS (TTM) vs TTM 1 Yr. Ago 67.90 -- --
EPS - 5 Yr. Growth Rate -- 9.86 10.79
Capital Spending - 5 Yr. Growth Rate -35.32 15.30 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.18
Current Ratio (MRQ) 0.93 2.88 2.98
LT Debt to Equity (MRQ) 0.00 9.47 11.56
Total Debt to Equity (MRQ) 68.10 13.43 15.81
Interest Coverage (TTM) -- 36.29 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.14 54.83
Gross Margin - 5 Yr. Avg. -- 52.29 52.40
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -1,784.27 18.46 15.24
Operating Margin (TTM) -- 14.50 7.76
Operating Margin - 5 Yr. Avg. -1,832.94 14.42 10.75
Pre-Tax Margin (TTM) -- 14.95 8.57
Pre-Tax Margin - 5 Yr. Avg. -2,046.43 14.74 11.17
Net Profit Margin (TTM) -- 11.22 4.88
Net Profit Margin - 5 Yr. Avg. -2,052.96 11.08 7.47
Effective Tax Rate (TTM) -- 23.21 23.11
Effective Tax Rate - 5 Yr. Avg. -- 23.44 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 953,213,828 864,673,321
Net Income/Employee (TTM) -1,118,643 112,151,383 101,717,508
Receivable Turnover (TTM) -- 5.60 5.76
Inventory Turnover (TTM) -- 2.58 3.34
Asset Turnover (TTM) 0.00 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -23.32 11.42 11.00
Return on Assets - 5 Yr. Avg. -54.05 13.00 12.43
Return on Investment (TTM) -59.58 14.86 14.46
Return on Investment - 5 Yr. Avg. -112.22 17.00 16.28
Return on Equity (TTM) -79.40 16.28 16.05
Return on Equity - 5 Yr. Avg. -184.67 18.03 17.51
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 77.79 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Galena Biopharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 23.13%
# of Holders: 50
Total Shares Held: 10,574,937
3 Mo. Net Change: -278,893
# New Positions: 4
# Closed Positions: 16
# Increased Positions: 13
# Reduced Positions: 27
# Net Buyers: -14
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.